BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1948543)

  • 1. [Importance of cytogenetics in the study of acute non-lymphoblastic leukemias].
    Prieto F; Badía L; Palau F; Beneyto M; Montero MR; Martínez-Castellano F
    Sangre (Barc); 1991 Jun; 36(3):229-35. PubMed ID: 1948543
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromosomal abnormalities in hematologic malignant diseases.
    Le Beau MM
    Prog Clin Biol Res; 1990; 340B():325-35. PubMed ID: 2203012
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of chromosome number deviations in myelodysplastic syndromes and in acute non-lymphoid leukemia].
    Balogh E; Oláh E; Nagy A; Kovács I; Kiss A
    Orv Hetil; 1989 Mar; 130(13):655-63. PubMed ID: 2657551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.
    So CC; Ma ES; Wan TS; Yip SF; Chan LC
    Leuk Res; 2008 Jun; 32(6):1000-1. PubMed ID: 17980911
    [No Abstract]   [Full Text] [Related]  

  • 5. 5q-: pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment.
    Pedersen B
    Anticancer Res; 1993; 13(5C):1913-6. PubMed ID: 8267400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetics and fluorescence in-situ hybridization in detection of hematological malignancies.
    Frenny VJ; Antonella Z; Luisa A; Shah AD; Sheth JJ; Rocchi M
    Indian J Cancer; 2003; 40(4):135-9. PubMed ID: 14716109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytogenetic anomalies in acute nonlymphatic leukemia].
    Becher R; Schmidt CG
    Dtsch Med Wochenschr; 1989 Feb; 114(6):227-30. PubMed ID: 2645100
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy-related acute leukemia.
    Karp JE; Sarkodee-Adoo CB
    Clin Lab Med; 2000 Mar; 20(1):71-81, ix. PubMed ID: 10702897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of cytogenetics in leukemias.
    VinSheth FJ; Sheth JJ; Patel AI; Shah AD; Verhest A
    Indian J Cancer; 2002; 39(4):139-42. PubMed ID: 12928572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal translocations in AML: detection and prognostic significance.
    Palanisamy N
    Cancer Treat Res; 2010; 145():41-58. PubMed ID: 20306244
    [No Abstract]   [Full Text] [Related]  

  • 11. Several chromosomes involved in translocations with chromosome 5 shown with fluorescence in situ hybridization in patients with malignant myeloid disorders.
    Bram S; Rödjer S; Swolin B
    Cancer Genet Cytogenet; 2004 Nov; 155(1):74-8. PubMed ID: 15527906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of occasional and clonal chromosome aberrations in patients with acute non-lymphocytic leukemia after autologous bone marrow transplantation.
    Testoni N; Martinelli G; Zaccaria A; Miggiano MC; Pelliconi S; Visani G; Manfroi S; Gherlinzoni F; Mangianti S; Tura S
    Bone Marrow Transplant; 1996 Dec; 18(6):1141-5. PubMed ID: 8971385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Karyotype and cell phenotypes in primary acute leukemias.
    Berger R; Bernheim A; Daniel MT; Valensi F; Flandrin G
    Blood Cells; 1981; 7(2):287-92. PubMed ID: 7028184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical picture and molecular disorders in myelodysplastic (MDP) syndromes].
    Rupniewska ZM
    Pol Arch Med Wewn; 1992 Mar; 87(3):197-208. PubMed ID: 1523148
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of complex chromosomal rearrangements in adult patients with MDS and AML by multicolor FISH.
    Babicka L; Ransdorfova S; Brezinova J; Zemanova Z; Sindelarova L; Siskova M; Maaloufova J; Cermak J; Michalova K
    Leuk Res; 2007 Jan; 31(1):39-47. PubMed ID: 16687173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cytogenetics and molecular genetics: detection and therapeutic strategy.
    Sandberg AA; Chen Z
    In Vivo; 1994; 8(5):807-18. PubMed ID: 7727729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome abnormalities in the myelodysplastic syndromes.
    Heim S; Mitelman F
    Clin Haematol; 1986 Nov; 15(4):1003-21. PubMed ID: 3552345
    [No Abstract]   [Full Text] [Related]  

  • 20. Robertsonian translocation (13;14)(q10;q10) in two young male myelodysplastic syndrome patients.
    Bakshi SR; Brahmbhatt MM; Trivedi PJ; Gajjar SB; Iyer RR; Joshi MS; Shukla SN; Shah PM
    Cancer Genet Cytogenet; 2006 Dec; 171(2):130-1. PubMed ID: 17116494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.